EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association Between Advanced Glycation End Products and Sarcopenia: The Mediating Role of Osteoporosis

Xingyu Zhang iD, Xiaoyu Chen, Shengjie Li, Mengze Gao, Peipei Han, Liou Cao, Jing Gao, Qiongying Tao, Jiayi Zhai, Dongyu Liang, Li Qin, Qi Guo iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Xingyu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai 201318, China. Hauptthemen laut MEDLINE: Sarcopenia, Osteoporosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Capacity Building project of Local Colleges of Shanghai Science and Technology Commission, Shanghai Sailing Program, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Advanced glycation end products (AGEs) are a group of molecules formed through nonenzymatic reactions. These compounds are associated with several age-related diseases, including sarcopenia and osteoporosis.

Objective

This work aimed to investigate the relationships between AGEs, osteoporosis, and sarcopenia in community-dwelling older adults.

Methods

This cross-sectional study included 1991 older adults aged 72.37 ± 5.90 years from China. AGE levels were measured by the AGE Reader device. Bone mineral density was assessed using dual-energy X-ray absorptiometry, and osteoporosis was diagnosed based on a T score of less than −2.5. Sarcopenia was defined as loss of muscle mass plus loss of muscle strength and/or reduced physical performance. Presarcopenia was defined as low muscle mass with normal muscle strength and normal physical performance.

Results

The prevalence of sarcopenia was 18.5%, and that of osteoporosis was 40.5%. Compared to the lowest AGE quartile, the highest AGE quartile showed a significant association with sarcopenia (odds ratio [OR] 2.42; 95% CI, 1.60-3.66) (P for trend <.001), but not with presarcopenia. Per-SD increase in AGE was associated with higher odds of sarcopenia (OR 1.44; 95% CI, 1.26-1.66). Additionally, in the mediation analysis, when AGEs were treated as a continuous variable (the mediation effect is denoted by Za*Zb = 18.81; 95% CI, 8.07-32.32]—the 95% CI does not contain zero, representing a significant mediating effect) or a categorical variable (the mediating effect is expressed as Zmediation = 3.01 > 1.96, which represents a significant mediating effect), osteoporosis played a partial mediating role in the association between AGEs and sarcopenia.

Conclusion

Elevated AGEs are associated with sarcopenia but not with presarcopenia. This association was partially mediated by osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaOsteoporosisHumansAgedCross-Sectional StudiesMuscle StrengthBone DensityAbsorptiometry, PhotonGlycation End Products, AdvancedHand Strength

Stichwörter der Autor:innen

advanced glycation end productsosteoporosissarcopenia

Substanzen

Glycation End Products, Advanced

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai 201318, China.
  • Tianjin Key Laboratory of Exercise Physiology and Sports Medicine, Institute of Sport, Exercise & Health, Tianjin University of Sport, Tianjin 300381, China.
  • Department of Nephrology, Molecular Cell Lab for Kidney Disease, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • General Practice Clinic, Pujiang Community Health Service Center in Minhang District, Shanghai 201112, China.
  • Jiading Subdistrict Community Health Center, Shanghai 201899, China.
  • Clinical Research Center, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.

ORCID-Profile: Xingyu Zhang, Qi Guo

Förderung

  • Capacity Building project of Local Colleges of Shanghai Science and Technology Commission
  • Shanghai Sailing Program
  • Shanghai Municipal Health Commission

Zitieren

APA

Zhang, X., Chen, X., Li, S., Gao, M., Han, P., Cao, L., Gao, J., Tao, Q., Zhai, J., Liang, D., Qin, L., & Guo, Q. (2024). Association Between Advanced Glycation End Products and Sarcopenia: The Mediating Role of Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad640

Vancouver

Zhang X, Chen X, Li S, Gao M, Han P, Cao L, et al. Association Between Advanced Glycation End Products and Sarcopenia: The Mediating Role of Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad640

BibTeX
@article{Zhang2024,
  author = {Zhang, Xingyu and Chen, Xiaoyu and Li, Shengjie and Gao, Mengze and Han, Peipei and Cao, Liou and Gao, Jing and Tao, Qiongying and Zhai, Jiayi and Liang, Dongyu and Qin, Li and Guo, Qi},
  title = {Association Between Advanced Glycation End Products and Sarcopenia: The Mediating Role of Osteoporosis},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad640}
}
Kostenlos starten →